We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

APA:ASXAPA Group Analysis

Data as of 2026-08-31 - not real-time

A$10.89

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

At AUD 10.89, APA Group shows a bullish moving-average alignment, with shorter averages sitting above longer ones. It has gained 7.0% over the past 30 days. RSI sits at 74.1, which reads as overbought, and MACD momentum is bullish. Price has been bracketed by support at AUD 9.76 and resistance at AUD 10.94.
On valuation the read is overvalued — earnings multiple of 68.1 versus a 19.4 sector average, above the peer group. Sell-side targets cluster 10.3% below the current quote. Revenue is contracting at 12.3% on a 6.9% profit margin. The 5.39% dividend yield looks stretched against payout coverage.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 15.8%, a beta of -0.20 and a maximum drawdown of 9.5%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons diverge: hold near-term but sell on a long view, at 5/10 conviction over the longer horizon.

Top Market Events

The company is paying a 58 cents per share dividend in FY 2026.Detailed price information for Apa Group Stapled Sec APAJF from The Globe and Mail including charting and trades.Detailed price information for Apa Group Stapled Sec APAJF from The Globe and Mail including charting and trades.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • RSI at 74.1 signals overbought conditions
  • Trading above the 200-day average of 9.72

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • RSI at 74.1 signals overbought conditions
  • P/E of 68.1 versus sector average of 19.4

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • P/E of 68.1 versus sector average of 19.4
  • Dividend yield of 5.39% looks stretched against payout coverage
  • Analyst targets imply -10.3% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth-12.30%
Profit Margin6.89%
P/E Ratio68.1
ROE8.72%
ROA3.33%
Debt/Equity525.71
P/B Ratio5.3
Op. Cash FlowA$1.3B
Free Cash FlowA$135.8M
Industry P/E19.4

Technical Analysis

TrendBullish
RSI74.1
SupportA$9.76
ResistanceA$10.94
MA 20A$10.29
MA 50A$10.21
MA 200A$9.72
MACDBullish
VolumeIncreasing
Fear & Greed Index94.36

Valuation

Target PriceA$9.77
Upside/Downside-10.32%
GradeOvervalued
TypeBlend
Dividend Yield5.39%

Risk Assessment

Beta-0.20
Volatility15.81%
Sector RiskLow
Reg. RiskHigh
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.